共 18 条
[11]
Angiostatin expression in non-small cell lung cancer. Volm M,Mattern J,Koomagi R. Clinical Cancer Research . 2000
[12]
Tumor angiogenesis: therapeutic implication. Folkman J. New England Journal of Homeopathy . 1971
[13]
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Ingber D,Fujita T,Kishimoto S,et al. Nature . 1990
[14]
Extended Phase I Study of the oral vascular endothe lial growth factor (VEGF) receptor inhibitor PTK787/ZK 222584 in Combination with Oxaliplatiri/5-Fluorouracil (5-FU) /Leucovorin as first line treatment for metastatic colorectal cancer. W P Steward,et al. Proceedings of the American Society of Clinical Oncology . 2003
[15]
Recent Development of anticancer agents including Biotherapeutics in Japan. Shigeru Tsukagoshi. Biotherapy . 2003
[16]
The safety of adding angiogenesis inhibition into treatment for colorectal, breast, and lung cancer: the Eastern Cooperative Oncology Group’s (ECOG) experience with Bevacizumab ( anti-VEGF). R. Gray,et al. Proceedings of the American Society of Clinical Oncology . 2003
[17]
Endostatin: Are the 2 years up yet. Editorial. Journal of Clinical Oncology . 2002
[18]
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. O’ Reilly. Cell . 1979